May 22, 2026

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

Conexiant

May 22, 2026

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

Conexiant

May 21, 2026

Rehab May Improve Function in AS

Supervised rehabilitation and exercise-based therapies may improve function, pain, and bone health in ankylosing spondylitis, according to a new review.

Conexiant

May 21, 2026

New Target for Uveitis Therapy

Could targeting cGAS-STING represent a new treatment avenue for uveitis?

The Ophthalmologist

May 20, 2026

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Conexiant

May 18, 2026

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

Conexiant

May 14, 2026

Phase 3 Ixo-Vec Program Advances

Retinal Physician

May 14, 2026

Can Gene Therapy Deliver Durability?

At Retina World Congress, David A. Eichenbaum, MD, examined whether late-stage intravitreal gene therapies can reduce injection burden in nAMD.

Retinal Physician

May 14, 2026

Mismatch May Be Common in PJI Cultures

Multicenter study suggests variability across centers and higher mismatch in certain clinical settings.

Conexiant

May 14, 2026

Sex Differences Seen in Immune Cells

Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells

Conexiant